TLP Group’s PDS Biotechnology PDSB Stock Holding History

TLP Group’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-490	Closed	-$102K	–	347
2016 Q3	$102K	Buy	+490	New	+$97.1K	0.11%	214

Other funds holding PDSB

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TLP Group's PDSB Position: Q4 2016 in Review

TLP Group sold out of PDS Biotechnology (PDSB) in Q4 2016, closing a stake of 490 shares — an estimated $102K sold.

TLP Group first reported a position in PDSB in Q3 2016 and held it in 1 quarter. The position peaked at $102K in Q3 2016. 52 funds tracked by Wall St. Rank hold PDSB as of Q4 2016.

TLP Group reported no remaining PDS Biotechnology position as of Q4 2016 after selling out during the quarter.
TLP Group sold 490 PDS Biotechnology shares in Q4 2016, an estimated $102K.
TLP Group first reported a position in PDS Biotechnology in Q3 2016 and held it in 1 quarter.
TLP Group's PDS Biotechnology position peaked at $102K in Q3 2016.
52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2016.

Based on TLP Group's 13F filing for Q4 2016, filed 2 Feb 2017.